SANJIVANI PARANTERAL LIMITED

SANJIVIN.BO
Exchange BSE, Currency in INR
Loading price...

Overview

Previous Close--
Open--
Ask--
Bid--
Day's Range -
52 Week Range -
PE Ratio(TTM)--
Market Cap--
Volume₹NaN
Avg. Volume₹NaN
Face Value₹NaN
Dividend Yield--

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

PARTICULARS0123456789
Net Sales₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Total Expenditure₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Raw Materials₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Employees₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Selling, Administration Expenses₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Power and Fuel Cost₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Operating Profits₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
OPM%0%0%0%0%0%0%0%0%0%0%
Other Income₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Depreciation₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Interest₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Profit Before Tax₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Tax₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Profit After Tax₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Adjusted EPS₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
Net Profit Margin0%0%0%0%0%0%0%0%0%0%

Company Profile

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Mumbai, India
Website: https://www.sanjivani.co.in
Chairman & MD: Mr. Ashwani Anamisharan Khemka B.A
About Company:
Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.